Showing results (71-80 of 137) with videos related to
Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|July 17, 2013
Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis CDominique Larrey, Ansgar W Lohse, Christian Trepo, et al.Journal of Virology|October 19, 2007
Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependentSonia Molina, Valerie Castet, Lydiane Pichard-Garcia, et al.Journal of Viral Hepatitis|September 10, 2024
Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)Tangui Barré, Lucia Parlati, Marc Bourlière, et al.European Journal of Clinical Pharmacology|August 11, 2012
Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT)Sinem Ezgi Gulmez, Dominique Larrey, Georges-Philippe Pageaux, et al.Drug Safety|June 8, 2013
Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT)Sinem Ezgi Gulmez, Nicholas Moore, Georges-Philippe Pageaux, et al.Gut|October 25, 2013
In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant modelClaire Gondeau, Philippe Briolotti, Francia Razafy, et al.Journal of Hepatology|August 18, 2020
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related deathMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.Journal of Cannabis Research|June 11, 2022
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohortTangui Barré, Fabrice Carrat, Clémence Ramier, et al.Hepatology International|July 24, 2015
Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patientsPeter Ferenci, Rodrigo Aires, Kimberly L Beavers, et al.Health Science Reports|December 8, 2022
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir-grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)Jean-Pierre Bronowicki, Patrick Miailhes, Bertrand Hanslik, et al.Pageof 14